Throughout Yellowstone National Park, a network of autonomous recorders is listening day and night, capturing thousands of wolf howls. That audio feeds into AI models to learn how wolves communicate, move, and behave in the wild.

The work is a partnership between the nonprofit Colossal Foundation, the Yellowstone Wolf Project, Grizzly Systems, and Yellowstone Forever.…

The post Colossal Foundation Reaches $100M as Its 2025 Impact Report Spans AI-Decoded Wolf Howls to Keeping Species Off the Extinction List appeared first on Dallas Innovates.

The Dallas-based Colossal Foundation has announced a $500,000, five-year partnership with the Turner Endangered Species Fund to hasten recovery of the Bolson tortoise, North America’s largest and rarest tortoise species, within its prehistoric range, marking a critical advancement for Pleistocene rewilding efforts.…

The post Colossal Foundation Invests $500K to Restore America’s Largest Tortoise to the Southwest appeared first on Dallas Innovates.

It made perfect sense that organizers of last week’s 2025 Annual Venture Dallas Conference chose the private library of Dallas billionaire Harlan Crow as the setting for their kickoff VIP Reception. The invite-only reception, after all, was sponsored by the NYSE Texas stock exchange, which in August had leased 28,000 square feet at Crow’s swank Old Parkland office campus in Dallas’ Oak Lawn neighborhood.…

The post ‘There’s So Much Energy in Our Space’: Innovators, Investors Invigorate Sold-Out 2025 Venture Dallas Conference appeared first on Dallas Innovates.

Colossal Biosciences, the Dallas-based de-extinction startup working to bring back the woolly mammoth, Tasmanian tiger, and dodo bird, just made its first acquisition. It has acquired Viagen Pets and Equine, a Texas company that’s been cloning animals commercially since 2002.

The pairing brings together a $10.3 billion decacorn known for seemingly impossible science with a company that’s cloned 15 species, including endangered ones, and runs a commercial pet cloning business with a five-to-seven month waitlist.…

The post Dallas Decacorn Colossal Buys Viagen, a Texas Pioneer in Animal Cloning appeared first on Dallas Innovates.

Ahead of the fifth annual Venture Dallas conference at the George W. Bush Presidential Center, Rachel Racz, Nasdaq Head of Listings for Texas, Southern U.S., and Latin America, and Sam L. Susser, Chairman and CEO of Susser Bank, honored the up-and-coming entrepreneurs and innovators fueling the growth of Dallas as an important hub of financial activity.…

The post Venture Dallas Hosts Startup of the Year Semi-Finalists at Petroleum Club appeared first on Dallas Innovates.

Dallas-based Colossal Biosciences—a “de-extinction” company that became Texas’ first “decacorn” in January with a valuation of $10.2 billion—announced a new nine-figure add-on to its Series C raise and offered an update on its attempts to bring back the dodo bird.

On the funding side, Colossal announced an additional expansion of $120 million in new funding with participation from USIT, Bob Nelsen, and “Lord of the Rings” director Peter Jackson, driving its Series C raise up from $200 million to $320 million.…

The post Colossal Raises Another $120M, Announces Pigeon Cell Breakthrough to Help ‘De‑Extinct’ the Dodo appeared first on Dallas Innovates.

Noted programmer and AI entrepreneur John Carmack, the founder of Keen Technologies, and biotech innovator Ben Lamm, co-founder and CEO of Colossal Biosciences, will take the stage together at the fifth annual Venture Dallas conference to discuss artificial general intelligence (AGI) and de-extinction—two ambitious frontiers in technology.…

The post AGI and De-Extinction: John Carmack and Ben Lamm Join Venture Dallas 2025 Lineup appeared first on Dallas Innovates.

Renowned Australian de-extinction scientist Andrew Pask has been appointed chief biology officer of Dallas-based Colossal Biosciences.

Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.…

The post Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer appeared first on Dallas Innovates.

Months after turning its dire wolf de-extinction into a moonshot milestone, Colossal Biosciences is going bigger—and taller. The company, now Texas’ first decacorn with a valuation of more than $10 billion, has unveiled plans to recreate New Zealand’s giant moa: a 12-foot-tall, 500-pound flightless bird that’s been extinct for six centuries.…

The post Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone appeared first on Dallas Innovates.

Two Dallas companies just landed on TIME’s 2025 list of the 100 most influential companies—and a third, now a $2 billion brand, started here. They join the likes of Waymo, OpenAI, and Amazon on the global list.

Dallas-based LTK, a global force in influencer commerce, and Colossal Biosciences, the biotech company working to restore extinct species and protect endangered ones, were both named to the list.…

The post Two Dallas Companies Land on TIME100 Most Influential—Alongside the World’s Biggest Brands appeared first on Dallas Innovates.

“He did this because others were too afraid to do it.”

Ben Lamm
Co-founder and CEO
Colossal Biosciences
.…on how he’d want his obituary to read, via TechStuff podcast.

Ben Lamm knows the work he and the team at Colossal Bioscience are doing pushes boundaries—and not everyone is cheering from the sidelines. …

The post The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl appeared first on Dallas Innovates.

It’s only in its second year, sure. But already, Dallas Innovates’ AI 75—a partnership with the Dallas Regional Chamber—has become the go-to standard for identifying and honoring the most innovative leaders in artificial intelligence in Dallas-Fort Worth.

Just look at the last 12 months.…

The post Who Made This Year’s AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence appeared first on Dallas Innovates.

A sound not heard on Earth for more than 12,500 years is back. The howl of a dire wolf—extinct since before recorded history and known to most through “Game of Thrones”—has returned, according to Dallas-based Colossal Biosciences.

The company announced today the successful birth of three dire wolves, calling it the world’s first true de-extinction.…

The post Hear the Howl: Dallas De‑Extinction Company Colossal Biosciences Brings Back Dire Wolf Using Ancient DNA appeared first on Dallas Innovates.

It may not be as massive as a woolly mammoth. But the Colossal Woolly Mouse is still big news—and an early sign of the potential of “de-extinction” technology.

Dallas-based Colossal Biosciences—which reached a valuation of $10.2 billion in January, becoming Texas’ first “decacorn”—is a genetic engineering and de-extinction company.…

The post Meet the Colossal Woolly Mouse, Created by Dallas-Based ‘Decacorn’ Colossal Biosciences appeared first on Dallas Innovates.

It’s not every day a 90-year-old helicopter company and a biotech startup bringing back extinct species share the same stage. But at D CEO and Dallas Innovates’ 2025 Innovation Awards, that’s exactly what happened—and it captures the spirit of North Texas innovation right now.…

The post Dallas-Fort Worth Innovation Breakthroughs Mark 2025 Awards appeared first on Dallas Innovates.

Dallas-based Colossal Biosciences is making history—again.

The world’s first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, has become Texas’ first “decacorn”—startup speak for a private company valued at more than $10 billion—after securing $200 million in new funding.…

The post Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding appeared first on Dallas Innovates.

The Colossal Foundation, the nonprofit arm of Dallas-based Colossal BioSciences, has announced a $1.5 million donation to Dr. George Church’s lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Colossal, a leading organization focused on pioneering innovative scientific solutions for conservation and biodiversity, said the funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts.…

The post Colossal Foundation Donates $1.5M to Harvard-Based Institute to Advance Artificial Womb Tech for Wildlife Conservation appeared first on Dallas Innovates.

The Colossal Foundation, the Dallas-based nonprofit arm of Colossal BioSciences has made an initial $1 million donation of its $3 million commitment to the Pask & Frankenberg Lab at the University of Melbourne in Australia to advance research and conservation efforts against chytridiomycosis, a fungal disease responsible for the extinction of at least 90 amphibian species worldwide and significant declines in over 500 other species.…

The post Dallas’ Colossal Foundation Donates $1M to Help Save Amphibians from Mass Extinction appeared first on Dallas Innovates.

The world’s first “de-extinction” company, Dallas-based Colossal Biosciences, has formed The Colossal Foundation, announcing $50 million in new funding and the initial flagship projects in its conservation agenda—including Colossal Biovault, “the world’s largest distributed biobanking initiative.”

That biobanking effort is a hot topic these days.…

The post Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More appeared first on Dallas Innovates.

…

The post Presenting the First-Ever AI 75: Meet the Most Innovative Leaders in Artificial Intelligence in Dallas-Fort Worth appeared first on Dallas Innovates.